Our Team

Founders

Christy Jagdfeld

Denise Calaprice-Whitty

Diana Pohlman

Founder and Chief Executive Officer
Christy Jagdfeld
Christy Jagdfeld is a CPA who resides in the Lake Country area of Wisconsin. She became a fierce patient advocate after her youngest child was diagnosed with several chronic illnesses in 2012.
Jagdfeld worked for six years as a volunteer and eventual Board Member and Treasurer of Dysautonomia International from 2014 to 2020. During that time, she organized a local 200 person annual awareness event, an in-person 5K Fundraising Event, and a successful 300 patient and clinician seminar on POTS & Dysautonomia held at St. Luke’s in Milwaukee.
She was co-chair of the Dysautonomia International Wisconsin Support group with 1000+ members and helped organize monthly in-person meetings, many with speakers. She attended local conferences and spoke at local events. On a national level, she helped with fundraising, networking, attending professional conferences and handled many of the business aspects of the organization.
Through a fellow board member of Dysautonomia International, Jagdfeld was introduced to the concept
another organization was utilizing that was driving research at a faster pace by providing funding and bio-samples directly to researchers in the Lyme world. That concept was one that Jagdfeld hoped to apply to other chronic illness that lacked funding and overall “coordinated” research.
In the fall of 2020, Jagdfeld joined the board of PANDAS Network as Treasurer. While there, she helped work with the executive director, Diana Pohlman, to implement policies and procedures, overhaul their current website, organize a virtual conference, attract new sponsors, start a Patient Advisory Committee, and start the process of getting a unique research roadmap created for PANDAS and PANS research.
In November of 2021, Jagdfeld was introduced to Dr. Denice Calaprice-Whitty who has an extensive and impressive background in neuroinflammatory illness research and data analysis. Calaprice-Whitty had recently joined the Scientific Advisory Board of PANDAS Network.
A discussion of overlapping interests in a patient registry, patient biobank, and coordinated researcher funding led to the creation of the Brain Inflammation Collaborative in December of 2021. Jagdfeld hopes that this concept can be shared across many illness models as advocacy groups push for platforms to help their patients, clinicians, and researchers.
In addition to her passion for patient advocacy, she shares a love for competitive swimming, music and the arts with her husband and three children. She continues to serve on the Board of Directors for Waukesha Express Swim Team since 2012. She credits swimming and caring coaches with helping her youngest through some of the hardest times of her life battling chronic illness. She looks forward to the
day when families no longer have to spend long and often devastating years searching for a diagnosis –
that they are able to find answers from the beginning.

Principal Investigator, Unhide
Denise Calaprice-Whitty
After receiving her Bachelor’s degree in Biology from Harvard University and her MS and PhD from Princeton, Dr. Denise Calaprice-Whitty became an NIH fellow at Columbia University’s College of Physicians and Surgeons in the departments of Clinical and Genetic Epidemiology and Child Psychiatry. During her time at Columbia, her research on the psychoneuroimmunology of childhood anxiety and mood disorders led to the prestigious Young Investigator Award from NARSAD (National Alliance for Research on Schizophrenia and Depression).
Although she continues to work and publish in this field as an avocation, her post-Columbia career led her into industry, where she has spent more than two decades designing and directing clinical research programs and creating innovative development and operational strategies in a variety of settings. Her positions have included Senior Director of Immunology Therapeutics at IQVIA (then Quintiles), Head of Clinical Research for North America at Altana/BykGulden, and Senior Director of Clinical Research at Regeneron. Dr. Calaprice has been consulting since 2006, including high-profile engagements with the Department of Defense under the Obama Administration (optimizing defense against biological warfare); with industry consortia such as The Avoca Quality Consortium, the Avoca Innovation Alliance, and Metrics Champion Consortium; and with numerous individual companies from the biggest international pharma to Silicon Valley start-ups and incubators.
Among her many accomplishments in this capacity, Dr. Calaprice developed the novel metrics taxonomy that was used by Pfizer to optimize its clinical research operations in the years just prior to Covid, and that has now been adopted by many of the world’s most prominent pharma. She has presented to FDA about her industry research and innovations, and on behalf of a variety of specific immunotherapies, on numerous occasions; and publishes and presents frequently for both medical and industry publications and conferences.

Patient Insight Advisor
Diana Pohlman
Diana Pohlman is the Founder and Executive Director of a public advocacy nonprofit, PANDAS Network (PN) founded in 2009 that has served thousands of patients worldwide. Through stakeholder outreach and collaboration with healthcare experts, the organization has contributed in the expansion of public advocacy and scientific research of the impact of blood brain barrier damage and autoimmune encephalitic processes. As a parent with two children who suffered from and overcame basal ganglia encephalitis, she is a fierce advocate for patient rights and clinical care for this underserved population. In 2013, PN was honored to be chosen as a National Institute of Mental Health Outreach
Partner. PN continues to be the leader in driving awareness of this emerging encephalitic illness (PANDAS/PANS).
The primary initiative of PN has been to lead the investigation in early research of the PANDAS/PANS diseases and other forms of autoimmune encephalitis via seed-money grants to variety of cutting edge researchers in the U.S. This has proven to be a critical step in the growing recognition of this illness. Public awareness has been at the core of reaching patients and doctors. Since 2011, Diana and her team at PN has been involved in the sponsoring over nine conferences, serving over 6,000 people, in the U.S. and Europe. Expanding accessibility for talented researchers and clinicians, building community for families and practitioners, while creating interdisciplinary medical practices is central to the core mission of her fifteen years of advocacy.
Diana’s long-term goal is to wipe out the devastation of encephalitic illnesses like PANDAS/PANS, autoimmune encephalitis and Sydenham chorea and tie our community’s cutting-edge research into the growing revelations surrounding the crosstalk of the immune system and the brain. Identifying patients and getting them expeditious care and excellent medical treatment must be achieved in this next decade.
Scientific & Medical Advisors

Jennifer Frankovich, MD, MS

Margo Thienemann, MD

Cristin MacDonald, Ph.D.

Satish Raj, MD MSCI

Matthew Menendez, Ph.D.

Ming Ta Micheal Lee, Ph.D.

Nicole Laurent, LMHC

Marni Graveline, M.A.

Jennifer Frankovich, MD, MS
Jennifer Frankovich, MD MS is a Clinical Professor in the Department of Pediatrics, Division of Allergy, Immunology Rheumatology (AIR) at Stanford University/Lucile Packard Children’s Hospital (LPCH). Dr. Frankovich’s clinical expertise is in systemic inflammatory and autoimmune diseases that co-occur with psychiatric symptoms. She completed her training in pediatrics, pediatric rheumatology, and clinical epidemiology at Stanford. Dr. Frankovich directs the Stanford PANS Program (2012- present) and along with her collaborators have created a longitudinal clinical database and large biorepository of patient and control biospecimens.
In addition to generating clinical data to better understand the PANS illness, she is collaborating with over 15 basic science labs who aim to understand the immunological underpinnings of the illness. Dr. Frankovich also co-led the development of evaluation and treatment guidelines for post-infectious neuropsychiatric conditions including PANS and autoimmune encephalitis. The Immune Behavioral Health Research program has been recently named a site for an upcoming sponsored Phase III, placebo controlled double blind IVIG Clinical Trial and Dr. Frankovich is also co-leading an Autism “wearables” study at Stanford with genomist Mike Snyder, PhD. Her over-arching career goal is to develop better diagnostic algorithms and treatment pathways for children with sudden severe psychiatric deteriorations caused by post-infectious inflammatory processes.

Margo Thienemann, MD
Dr. Thienemann helped develop the first clinic in the country exclusively devoted to PANS patients. She is the co-author of the first clinical diagnosis and treatment guidelines for PANS. Dr. Thienemann has been working as a clinician both as a private psychiatrist and a clinical professor at Stanford University for over 20 years and continues to work on innovative research avenues for this underserved population.

Cristin MacDonald, Ph.D.
Cristin MacDonald provides consulting services to top pharmaceutical, biotech, and contract research organizations, and oversees client deliverables, systems, and processes.
Crissy has over 15 years of experience with expertise in clinical research, process development, and strategic management. Her previous roles have touched every stage of the clinical trials process, from pre-clinical research through late-stage clinical development.
Crissy earned a Ph.D. in biomedical engineering from Drexel University and a bachelor’s degree from Lafayette College.

Satish Raj, MD MSCI
Satish R Raj MD MSCI is a Professor of Cardiac Sciences and the Section Chief of the Cardiac Arrhythmia Group at the University of Calgary in Canada. He also serves as the Director of Education at the Libin Cardiovascular Institute in the University of Calgary’s Cumming School of Medicine.
He was recruited to the University of Calgary in 2014 from the Vanderbilt University Autonomic Dysfunction Center, and founded the Calgary Autonomic Investigation & Management Clinic. He runs an active research program in Human Autonomic Physiology. His primary research interests relate to understanding and better treating postural orthostatic tachycardia syndrome (POTS), a disorder that primarily affects women.

Matthew Menendez, Ph.D.
Dr. Matthew Menendez obtained his Ph.D. in Microbiology from the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma. His primary research focus was understanding how and why the obligate intracellular parasite Toxoplasma gondii alters the metabolic profile of its host cell, mimicking the metabolism of activated immune cells, such as those found in neuroinflammatory and autoimmune diseases.
After graduate school, Dr. Menendez pursued a postdoctoral fellowship in cardiovascular biology in Dr. Courtney Griffin’s Lab at the Oklahoma Medical Research Foundation. While at OMRF, Dr. Menendez was awarded an American Heart Association postdoctoral fellowship, which supported his research efforts and enabled him to publish numerous papers investigating the regulation of capillary vessel stability and how blood vessel permeability can stimulate macrophages to regulate the function of lymphatic vessels.
Dr. Menendez is passionate about helping scientists obtain the research support they need to answer important medical questions that have limited financial support from government funding agencies. He achieves this by leveraging his digital marketing agency, Empirical Web Solutions, to help medical nonprofits secure the fundraising support required to address some of the most important, yet underfunded, scientific questions of our time.

Ming Ta Micheal Lee, Ph.D.
Ming Ta Michael Lee graduated from the University of Cambridge in 2002 with a Ph.D. in virology. Afterward, he joined Dr. Bryan Cullen’s lab as a Research Associate at Howard Hughes Medical Institute at Duke University Medical Center. He then joined Dr. Yuan-Tsong Chen’s group as a postdoctoral researcher at the Institute of Biomedical Sciences, Academia Sinica in 2003 and was promoted to Assistant Director at the National Center for Genome Medicine (NCGM) in 2004 and Assistant Research Scientist in 2008. He was invited to join the Center for Integrative Medical Sciences at RIKEN as Team Leader of the Laboratory for International Alliance in Japan. He then joined the Genomic Medicine Institute at Geisinger as an Associate Professor and Associate Director of Geisinger Biobank in 2016. He is now the VP of Biobank Operations at Geletea Bio, Inc. Dr. Lee still maintains his academic affiliations with Academia Sinica and RIKEN.
Dr. Lee is an internationally recognized geneticist for identifying genetic associations with complex diseases and pharmacogenetics (PGx) studies by utilizing large datasets integrating electronic health records (EHR), genetic data, and medical images. He has made major contributions in the PGx field where he identified genetic variants associated with warfarin, lithium, and phenylephrine response, as well as, genetic variants associated with NSAID-induced hypersensitivity, and anti-tuberculosis and anti-HIV drug-induced liver toxicity in individuals with African ancestry. He carried out clinical studies demonstrating the clinical utility of PGx tests in reducing drug-induced adverse events. In complex diseases, Dr. Lee identified genetic variants associated with bipolar disorder, schizophrenia, Sjögren’s syndrome, stroke, osteoarthritis, spine degeneration, and PCOS. In rare disease research, he identified genetic variants underlying Cleidocranial Dysplasia. Together with extensive bench experience in cellular and animal models of diseases, his research experience has resulted in high-impact publications including the New England Journal of Medicine.
Dr. Lee also has an active presence on the international stage where he plays key roles in international consortia, such as the International Warfarin Pharmacogenetics Consortium (IWPC), Clinical Pharmacogenetic Implementation Consortium (CPIC), International Genetics of Osteoarthritis (GO) and The Pharmacogene Variation (PharmVar) Consortium. In addition to his research accomplishments, Dr. Lee has had management experience in biobanking and clinical certification including CLIA and CAP accreditation, the development of genetic biomarker assays, and has provided expertise on genetic variant patent filing, and regulatory submissions to the FDA, TFDA and EMA.

Nicole Laurent, LMHC
Nicole Laurent, MA, is a licensed mental health counselor with a rich background spanning over 15 years in private practice. During this time, she has utilized therapies such as Dialectical Behavior Therapy (DBT), Cognitive Behavioral Therapy (CBT), and Eye Movement Desensitization and Reprocessing (EMDR) and now integrates them with the use of nutritional and metabolic therapies to better support the “bio” of the biopsychosocial model of her practice. She holds an MA in Clinical Psychology from Argosy University, a Post-Graduate Certificate in Nutrition and Integrative Health from the Maryland University of Integrative Health (MUIH), and advanced training in the use of Ketogenic Metabolic Therapy for Mental Illness and Neurological Disorders.
Expanding her reach beyond traditional counseling, Nicole also offers individual consultations and leads an online program, both aimed at facilitating access to ketogenic metabolic therapies, a vital resource not yet standardized in current treatment models.
In her ongoing commitment to advancing the field of metabolic psychiatry, Nicole has spearheaded initiatives that foster collaboration and knowledge sharing among clinicians. She founded the Clinical Psychology Case Studies Working Group, a community that encourages professionals to explore and publish insights on the effectiveness of ketogenic metabolic therapy.
In 2022, Nicole’s efforts were recognized with the Metabolic Mind Award, an accolade that honors individuals making strides in the application of ketogenic metabolic therapy in the mental health sector. This award, given by the Baszucki Brain Research Fund in partnership with the Milken Institute’s Center for Strategic Philanthropy, acknowledges Nicole’s active role in expanding the reach, understanding, and clinical practice of metabolic psychiatry.
Nicole developed and leads the first NBCC-approved continuing education program on Metabolic Psychiatry for Nonprescribers, a crucial initiative that equips psychologists and allied mental health professionals with the knowledge to support patients adopting ketogenic diets as a treatment method.
Nicole is also a member of the Clinician Advisory Committee at the nonprofits Metabolic Mind and Keto Live Project, contributing to shaping strategies and initiatives in the hopes of offering valuable insights into the psychosocial aspects of implementing ketogenic metabolic therapies.

Marni Graveline, M.A.
Marni Graveline, M.A., is a Director of Educational Services and a School Psychologist with 25 years of experience in public and private educational settings. Before working in education, Marni worked in mental health services at a locked psychiatric facility supporting patients’ social/emotional needs. She holds a B.A. and M.A. in Psychology with specialization in School Psychology and Counseling. Marni earned her National Credential in School Psychology (NCSP) after graduation in 1996. Her passion for supporting struggling learners has fueled Marni’s career working in the education and counseling fields. Marni has used her skill set to support multiple areas in counseling and education from social and emotional needs, executive functioning, academic and cognitive skill development, and advocacy within school and work settings. Along with her college degrees, Marni holds a Structured Literacy Dyslexia Interventionist credential from the International Dyslexia Association’s Center for Effective Reading Instruction. She also has worked with students with complicated mental health concerns to support their needs and ongoing development. Suicide Prevention is an area where she has expanded her skills over the years, and provides individual support services. Marni enjoys being married with two adult children and a dog. Her involvement with the Tacoma City Ballet as a character dancer in ballet productions and traveling to see family helps her keep balance.
Staff

Christina

Melanie

Renee

Marion

Neva

Heather

Ryan

Will

Nathan

Alice
Patient Advisor

Francie Fitzgerald

Patient Advisor
Francie Fitzgerald
Francie Fitzgerald is a clinical social worker providing dialectical behavior therapies at Jefferson University Hospital in Philadelphia, Pennsylvania. After graduating from the University of Notre Dame where she studied neuroscience, she pursued her Masters in Social Work at the University of Pennsylvania. Since being diagnosed with postural orthostatic tachycardia syndrome at the age of 15, Francie has devoted herself wholeheartedly to bettering the lives of those affected by dysautonomia and related conditions. Francie was ultimately diagnosed with Ehlers-Danlos syndrome after developing multiple pain syndromes and immune-mediated co-morbidities. She is active in the review of research proposals to private philanthropies and nonprofit organizations. Her professional passion is adapting empirically supported mental health therapies to chronic illness patient populations. Francie currently lives with her partner, Mark, service dog, Paddy, and kitten, Lisko, all of whom bring her endless joy and provide her beautiful care in their special way.